Publisher
Springer Berlin Heidelberg
Reference109 articles.
1. AGIS Investigators (2000): The advanced glaucoma intervention study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 130: 429–440
2. American Academy of Ophthalmology Retina/Vitreous Panel, Preferred Practice Pattern Guidelines (2015): Age Related Macular degeneration. San Francisco, CA, 2015. Age-Related Macular Degeneration PPP - Updated 2015 ( http://www.aao.org/preferred-practice-pattern/age-related-macular-degeneration-ppp-2015 )
3. Aroney C, Fraser-Bell S, Lamoureux EL, Gillies MC, Lim LL, Fenwick EK (2016): Vision-Related Quality of Life Outcomes in the BEVORDEX Study: A clinical trial comparing Ozurdex sustained release dexamethasone intravitreal implant and bevacizumab treatment for diabetic macular edema. Invest Ophthalmol Vis Sci. 57: 5541–5546
4. Behrens-Baumann W, Begall T (1993): Antiseptics versus antibiotics in the treatment of the experimental conjunctivitis caused by staphylococcus aureus. Ger J Ophthalmol 2: 409–411
5. Berg K, Pedersen TR, Sandvik L, Bragadóttir R (2015): Comparison of ranibizumab and bevacizumab for neovascular age-related macular degeneration according to LUCAS treat-and-extend protocol. Ophthalmology 122: 146–152